Cargando…

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention

Heart failure is an important manifestation of diabetic heart disease. Before the development of symptomatic heart failure, as much as 50% of patients with type 2 diabetes mellitus (T2DM) develop asymptomatic left ventricular dysfunction including left ventricular hypertrophy (LVH). Left ventricular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Mohapradeep, Dihoum, Adel, Mordi, Ify R., Choy, Anna-Maria, Rena, Graham, Lang, Chim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513785/ https://www.ncbi.nlm.nih.gov/pubmed/34660744 http://dx.doi.org/10.3389/fcvm.2021.746382

Ejemplares similares

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
por: Singh, Jagdeep S. S., et al.
Publicado: (2016)

Plasma desmosine for prediction of outcomes after acute myocardial infarction
por: Ali, Kashan, et al.
Publicado: (2022)

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
por: Singh, Jagdeep S.S., et al.
Publicado: (2020)

Evaluation of myocardial work in patients with hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy based on non-invasive pressure-strain loops
por: Zhao, Qingqing, et al.
Publicado: (2022)

Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality
por: Afify, Hesham M. A., et al.
Publicado: (2018)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Deep learning assessment of left ventricular hypertrophy based on electrocardiogram
por: Zhao, Xiaoli, et al.
Publicado: (2022)

Influence of Right Ventricular Dysfunction on Outcomes of Left Ventricular Non-compaction Cardiomyopathy
por: Wang, Wuwan, et al.
Publicado: (2022)

Left ventricular hypertrophy, diastolic dysfunction and right ventricular load predict outcome in moderate aortic stenosis
por: Stöbe, Stephan, et al.
Publicado: (2023)

Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients
por: Lopes, Elisangela C. P., et al.
Publicado: (2022)

Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy
por: Zhang, Xinyu, et al.
Publicado: (2022)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

Left ventricular dyssynchrony as marker of early dysfunction in premature ventricular contraction-induced cardiomyopathy
por: Kowlgi, Gurukripa N., et al.
Publicado: (2022)

Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension
por: Kim, Hyue Mee, et al.
Publicado: (2022)

A meta-analysis of the diagnostic value of microRNA for hypertensive left ventricular hypertrophy
por: Fei, Su-Hai, et al.
Publicado: (2022)

Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
por: Ferkh, Aaisha, et al.
Publicado: (2023)

Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction
por: Zhang, Lisha, et al.
Publicado: (2022)

The Association Between Left Ventricular Hypertrophy and the Occurrence and Prognosis of Atrial Fibrillation: A Meta-Analysis
por: Xiang, Huaqiang, et al.
Publicado: (2021)

Sex-Specific Associations of Anxiety With Left Ventricular Hypertrophy and Transmural Dispersion of Repolarization in Hypertensive Patients
por: Zhu, Ling, et al.
Publicado: (2022)

Development and validation of a rapid visual technique for left ventricular hypertrophy detection from the electrocardiogram
por: Somani, Sulaiman, et al.
Publicado: (2023)

Amino acid homeostasis is a target of metformin therapy
por: Forteath, Calum, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: de Oliveira, Maykon Tavares, et al.
Publicado: (2021)

Synergistic prognostic values of cardiac sympathetic innervation with left ventricular hypertrophy and left atrial size in heart failure patients without reduced left ventricular ejection fraction: a cohort study
por: Doi, Takahiro, et al.
Publicado: (2012)

Etiology-Discriminative Multimodal Imaging of Left Ventricular Hypertrophy and Synchrotron-Based Assessment of Microstructural Tissue Remodeling
por: Loncaric, Filip, et al.
Publicado: (2021)

Clinical Value of Complex Echocardiographic Left Ventricular Hypertrophy Classification Based on Concentricity, Mass, and Volume Quantification
por: Barbieri, Andrea, et al.
Publicado: (2021)

Prevalence of left ventricular hypertrophy in children and young people with primary hypertension: Meta-analysis and meta-regression
por: Sinha, Manish D., et al.
Publicado: (2022)

Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania
por: Lutale, JJK, et al.
Publicado: (2008)

Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

Left ventricular apical hypertrophy (Yamaguchi disease)
por: Al Lawati, Hatim, et al.
Publicado: (2021)

Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study
por: Mordi, Ify R., et al.
Publicado: (2021)

Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
por: Kishimoto, Hiroshi, et al.
Publicado: (2023)

Left Ventricular Remodeling in Non-syndromic Mitral Valve Prolapse: Volume Overload or Concomitant Cardiomyopathy?
por: Pype, Lobke L., et al.
Publicado: (2022)

A novel loss-of-function mutation in NRAP is associated with left ventricular non-compaction cardiomyopathy
por: Zhang, Zhongman, et al.
Publicado: (2023)

Two-dimensional strain profiles in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative analyses
por: Afonso, Luis, et al.
Publicado: (2012)

Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study
por: Bahramali, Ehsan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tfnert26aa4mpl5jt8i1lvj8m2